| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings, Inc. (DNA) has 2 insiders with recent SEC Form 4 filings, including 1 buy and 18 sells. DNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 24.3K | $219.8K | - | |
| Other | 7.5K | $67.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | Sloan Harry | Director | Buy | 350,000 | $1.28 | $448,000.00 | +493.5% | +23.5% | -39.0% | |
| May 18, 2023 | Canton Barry86 | 10% Owner | Sell | 75,300 | $1.28 | $96,271.05 | -0.3% | +23.5% | -39.0% | |
| May 18, 2023 | Shetty Reshma P.86 | See Remarks | Sell | 75,300 | $1.28 | $96,271.05 | -0.3% | +23.5% | -39.0% | |
| May 18, 2023 | Kelly Jason R86 | See Remarks | Sell | 200,000 | $1.28 | $255,700.00 | -1.0% | +23.5% | -39.0% | |
| May 11, 2023 | Canton Barry86 | 10% Owner | Sell | 75,300 | $1.34 | $100,600.80 | -0.3% | +51.1% | -42.8% | |
| May 11, 2023 | Shetty Reshma P.86 | See Remarks | Sell | 75,300 | $1.34 | $100,600.80 | -0.3% | +51.1% | -42.8% | |
| May 11, 2023 | Kelly Jason R86 | See Remarks | Sell | 200,000 | $1.34 | $267,200.00 | -0.9% | +51.1% | -42.8% | |
| May 4, 2023 | Shetty Reshma P.86 | See Remarks | Sell | 75,300 | $1.18 | $88,741.05 | -0.3% | +67.2% | -21.7% | |
| May 4, 2023 | Kelly Jason R86 | See Remarks | Sell | 200,000 | $1.18 | $235,700.00 | -0.9% | +67.2% | -21.7% | |
| May 4, 2023 | Canton Barry86 | 10% Owner | Sell | 75,300 | $1.18 | $88,741.05 | -0.3% | +67.2% | -21.7% |